Patents by Inventor Stephan Riedmaier

Stephan Riedmaier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9528156
    Abstract: A method for determining a predisposition of a patient to the development of muscular diseases and/or to changed biotransformation in a treatment of the patient with atorvastatin is disclosed. The presence of at least one single nucleotide polymorphism (SNP) in the UGT1A3 gene (uridine diphosphate glucuronosyltransferase gene 1A3) and/or an increased UGT1A3 gene expression is determined in a biological sample of the patient. The disclosure further relates to oligonucleotides that can be used in the method and to diagnostic kits that use the oligonucleotides.
    Type: Grant
    Filed: February 23, 2010
    Date of Patent: December 27, 2016
    Assignee: Robert Bosch GmbH
    Inventors: Kathrin Klein, Stephan Riedmaier, Ulrich Zanger
  • Publication number: 20120107814
    Abstract: A method for determining a predisposition of a patient to the development of muscular diseases and/or to changed biotransformation in a treatment of the patient with atorvastatin is disclosed. The presence of at least one single nucleotide polymorphism (SNP) in the UGT1A3 gene (uridine diphosphate glucuronosyltransferase gene 1A3) and/or an increased UGT1A3 gene expression is determined in a biological sample of the patient. The disclosure further relates to oligonucleotides that can be used in the method and to diagnostic kits that use the oligonucleotides.
    Type: Application
    Filed: February 23, 2010
    Publication date: May 3, 2012
    Applicant: Robert Bosch GmbH
    Inventors: Kathrin Klein, Stephan Riedmaier, Ulrich Zanger